Edgewise Therapeutics Inc (EWTX)
32.02
-0.85
(-2.59%)
USD |
NASDAQ |
Nov 15, 11:22
Edgewise Therapeutics Cash and Short Term Investments (Quarterly): 492.54M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 492.54M |
| June 30, 2024 | 511.75M |
| March 31, 2024 | 532.76M |
| December 31, 2023 | 318.39M |
| September 30, 2023 | 289.70M |
| June 30, 2023 | 309.93M |
| March 31, 2023 | 327.95M |
| December 31, 2022 | 351.95M |
| Date | Value |
|---|---|
| September 30, 2022 | 364.82M |
| June 30, 2022 | 248.40M |
| March 31, 2022 | 265.83M |
| December 31, 2021 | 280.79M |
| September 30, 2021 | 290.48M |
| June 30, 2021 | 299.15M |
| March 31, 2021 | 309.87M |
| December 31, 2020 | 129.09M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
129.09M
Minimum
Dec 2020
532.76M
Maximum
Mar 2024
332.71M
Average
309.90M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 442.33M |
| Cytokinetics Inc | 1.012B |
| Vanda Pharmaceuticals Inc | 376.26M |
| Vertex Pharmaceuticals Inc | 6.524B |
| Sarepta Therapeutics Inc | 1.198B |